Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial
Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial
Barbora de Courten
1
, MD,MPH,PhD,FRACP
;
Maximilian PJ de Courten
2
, MD,MPH
;
Casper G Schalkwijk
3
, PhD
;
Karen Z Walker
4
, BSc (Hons),MND,GradCert (Higher Ed),PhD
;
Josephine Forbes
5, 6
, PhD
1
Monash Centre for Health Research & Implementation
,
School of Public Health and Preventive Medicine
,
Monash University
,
Melbourne
,
AU
2
Centre for Chronic Disease
,
College of Health and Biomedicine
,
Victoria University
,
Melbourne
,
AU
3
Laboratory for Metabolism and Vascular Medicine
,
Experimental Internal Medicine
,
Maastricht University, Maastricht
,
6211 LK
,
NL
4
Department of Nutrition and Dietetics
,
Monash University
,
Melbourne
,
AU
5
Mater Research Institute- The University of Queensland
,
Glycation and Diabetes
,
TRI
,
South Brisbane
,
AU
6
Mater Clinical School
,
School of Medicine
,
University of Queensland
,
St Lucia
,
AU
Corresponding Author:
-
Barbora de Courten, MD,MPH,PhD,FRACP
-
Monash Centre for Health Research & Implementation
-
School of Public Health and Preventive Medicine
-
Monash University
-
43-51 Kanooka Grove
-
Clayton
-
Melbourne
-
AU
-
Phone:
61 3 9594 7086
-
Email: barbora.decourten@monash.edu